Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Doused in Denmark

David S. Pisetsky, MD, PhD  |  Issue: August 2009  |  August 1, 2009

David S. Pisetsky, MD, PhD

If any doubt about the growth of rheumatology worldwide still lingered, the European League Against Rheumatism (EULAR) congress in Copenhagen this June should have ended it. The meeting was not just big. It was gigantic and filled the sleek new Bella Center on the outskirts of the city. On the grounds of the Bella Center sits a large wind turbine which, while generating the nice green electricity, looked as if it was blowing hoards of rheumatologists through the entrance doors, jetting them into lecture halls and exhibit areas.

The crowding magnified the impression of the meeting’s size. The wide corridors were jammed with people who seemed relentlessly hungry for knowledge. Even in the caverns of the big auditoriums, the sessions were standing room only. On more than one occasion, I had to watch a lecture on a TV monitor outside a barricaded room assiduously guarded by a security officer, albeit a pleasant young woman.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE
Doused in Denmark

Soggy City

While the record number of attendees led to crowding, the weather was also a big factor keeping people inside the convention center. For the first four days I was there, rain pelted wonderful, wonderful Copenhagen and a fierce wind blasted fusillades of water across the city. We learned later that this was the wettest week in Copenhagen history and one day saw the ninth largest rain accumulation ever recorded in Denmark. People making their way from the subways arrived at the Bella Center drenched, their umbrellas blown apart in cyclonic winds.

I do not know what Danes call this weather, but in the United States, it would be a nor’ easter, although someone said it was like Katrina. With the weather preventing sightseeing and the only attraction around the Bella Center the wind turbine (and how many times can you watch it go around?), people probably logged a record number of CME hours. While standing during a session in a hot, densely packed lecture room, I turned to a friend and suggested that the best way to clear out the place would be to run down the aisle yelling, “The sun is shining, the sun is shining!” The stampede out the door would have been downright dangerous, although I would have finally gotten a seat.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Although the rain dampened the usual excitement of a meeting in a great capital of Europe— indeed, a beautiful gal of a town—I had many vivid impressions of EULAR. I anticipate that the ACR annual meeting in Philadelphia will reprise and amplify these themes.

A meeting with the climatic vicissitudes of the 2009 EULAR congress can’t help but inspire metaphors to describe the state of our specialty. I asked myself “What is the real rheumatology today?”

Plenty to Discuss for Rheumatology

Certainly, as many talks and posters demonstrated, therapy for inflammatory disease is advancing rapidly. Whether a speaker cited remission rates of 50% in the treatment of rheumatoid arthritis (RA) or described new agents to block diseases mediated by interleukin-1, the progress remains very impressive. As treatment moves forward, challenging questions will arise. Can patients in RA in remission stop their DMARDs (any or all)? If they stop therapy and relapse, can remission be recaptured? These are exciting new topics for inquiry that should provide a rich research agenda for the coming years.

Page: 1 2 3 | Single Page
Share: 

Filed under:EULAR/OtherMeeting ReportsOpinionRheuminationsSpeak Out Rheum Tagged with:DiseaseDisease-modifying antirheumatic drugs (DMARDs)EULARRheumatoid arthritisTravel

Related Articles

    EULAR Magic

    October 7, 2011

    Colorful characters and old friends meet in London

    Do RA Patients in Clinical Trials for Biologics Represent the Average?

    October 4, 2016

    It’s estimated that a majority of patients with rheumatoid arthritis (RA) have been exposed to biologic treatments. However, the randomized controlled trials demonstrating the safety and efficacy of these biologic agents have strict participant eligibility requirements. New research has examined the requirements of 30 trials for biologics and applied those standards to two large clinical cohorts. The result: A majority of these RA patients did not satisfy the criteria…

    Medical Renaissance

    February 12, 2011

    Europe has much that is new—including innovative research—emerging from its old-world settings

    March Madness on the High Seas: Hoops and Healthcare as Bedfellows

    June 1, 2010

    Hoops and healthcare as bedfellows

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences